619 related articles for article (PubMed ID: 19060482)
1. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
[TBL] [Abstract][Full Text] [Related]
2. Influence of endothelin-1 gene polymorphisms on the progression of autosomal dominant polycystic kidney disease.
Reiterová J; Merta M; Stekrová J; Cabartová Z; Cibulka R; Maixnerová D; Rysavá R; Ríhová Z; Tesar V; Motán J
Kidney Blood Press Res; 2006; 29(3):182-8. PubMed ID: 16943682
[TBL] [Abstract][Full Text] [Related]
3. Modifier effect of the Glu298Asp polymorphism of endothelial nitric oxide synthase gene in autosomal-dominant polycystic kidney disease.
Stefanakis N; Ziroyiannis P; Trygonis S; Lamnissou K
Nephron Clin Pract; 2008; 110(2):c101-6. PubMed ID: 18815450
[TBL] [Abstract][Full Text] [Related]
4. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
5. A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease.
Zeltner R; Hilgers KF; Schmieder RE; Porst M; Schulze BD; Hartner A
Nephron Clin Pract; 2008; 108(3):c169-75. PubMed ID: 18277079
[TBL] [Abstract][Full Text] [Related]
6. Study of candidate genes affecting the progression of renal disease in autosomal dominant polycystic kidney disease type 1.
Tazón-Vega B; Vilardell M; Pérez-Oller L; Ars E; Ruiz P; Devuyst O; Lens X; Fernández-Llama P; Ballarín J; Torra R
Nephrol Dial Transplant; 2007 Jun; 22(6):1567-77. PubMed ID: 17303584
[TBL] [Abstract][Full Text] [Related]
7. The influence of the endothelin-converting enzyme-1 gene polymorphism on the progression of autosomal dominant polycystic kidney disease.
Reiterová J; Merta M; Stekrová J; Tesar V; Kmentová D; Ríhová Z; Rysavá R; Viklický O
Ren Fail; 2006; 28(1):21-4. PubMed ID: 16526315
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease.
Magistroni R; Manfredini P; Furci L; Ligabue G; Martino C; Leonelli M; Scapoli C; Albertazzi A
J Nephrol; 2003; 16(1):110-5. PubMed ID: 12653106
[TBL] [Abstract][Full Text] [Related]
9. The influence of G-protein beta3-subunit gene and endothelial nitric oxide synthase gene in exon 7 polymorphisms on progression of autosomal dominant polycystic kidney disease.
Reiterová J; Miroslav M; Stekrová J; Kohoutová M; Tesar V; Kmentová D; Hubácek JA; Viklický O
Ren Fail; 2004 Mar; 26(2):119-25. PubMed ID: 15287194
[TBL] [Abstract][Full Text] [Related]
10. Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease.
Persu A; El-Khattabi O; Messiaen T; Pirson Y; Chauveau D; Devuyst O
Nephrol Dial Transplant; 2003 Oct; 18(10):2032-8. PubMed ID: 13679477
[TBL] [Abstract][Full Text] [Related]
11. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis.
Pereira TV; Nunes AC; Rudnicki M; Magistroni R; Albertazzi A; Pereira AC; Krieger JE
Nephrol Dial Transplant; 2006 Nov; 21(11):3155-63. PubMed ID: 16935894
[TBL] [Abstract][Full Text] [Related]
12. Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males.
Doi K; Noiri E; Nakao A; Fujita T; Kobayashi S; Tokunaga K
J Am Soc Nephrol; 2006 Mar; 17(3):823-30. PubMed ID: 16421229
[TBL] [Abstract][Full Text] [Related]
13. Influence of the alpha-adducin and ACE gene polymorphism on the progression of autosomal-dominant polycystic kidney disease.
Merta M; Reiterová J; Stekrová J; Rysava R; Rihová Z; Tesar V; Viklický O; Kmentova D
Kidney Blood Press Res; 2003; 26(1):42-9. PubMed ID: 12697976
[TBL] [Abstract][Full Text] [Related]
14. Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease.
Paterson AD; Magistroni R; He N; Wang K; Johnson A; Fain PR; Dicks E; Parfrey P; St George-Hyslop P; Pei Y
J Am Soc Nephrol; 2005 Mar; 16(3):755-62. PubMed ID: 15677307
[TBL] [Abstract][Full Text] [Related]
15. The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1.
Walker D; Consugar M; Slezak J; Rossetti S; Torres VE; Winearls CG; Harris PC
Am J Kidney Dis; 2003 Jan; 41(1):90-4. PubMed ID: 12500225
[TBL] [Abstract][Full Text] [Related]
16. [Progression of autosomic dominant polycystic kidney disease. Influence of endothelial NO synthase (ecNOS) and renin angiotensin system gene polymorphisms].
Azurmendi P; Fraga A; Muchnik C; Dos Ramos Farias M; Galan F; Guerra D; O'Flaherty M; Arrizurieta E; Martin R
Medicina (B Aires); 2004; 64(2):139-42. PubMed ID: 15628301
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiologic data, clinical and prognostic features of autosomal dominant polycystic kidney disease in a French region].
Simon P; Le Goff JY; Ang KS; Charasse C; Le Cacheux P; Cam G
Nephrologie; 1996; 17(2):123-30. PubMed ID: 8838759
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor gene 460 polymorphism is associated with pterygium formation in female patients.
Tsai YY; Chiang CC; Bau DT; Cheng YW; Lee H; Tseng SH; Tsai FJ
Cornea; 2008 May; 27(4):476-9. PubMed ID: 18434853
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.
Buraczynska M; Ksiazek P; Drop A; Zaluska W; Spasiewicz D; Ksiazek A
Nephrol Dial Transplant; 2006 Apr; 21(4):979-83. PubMed ID: 16384824
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor as an angiogenesis biomarker for the progression of autosomal dominant polycystic kidney disease.
Martins DP; Souza MA; Baitello ME; Nogueira V; Oliveira CI; Pinhel MA; Caldas HC; Filho MA; Souza DR
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
